Browse Category

NASDAQ:ABVX News 7 January 2026

Abivax stock jumps 7% on Nasdaq — here’s what’s moving ABVX and what’s next

Abivax stock jumps 7% on Nasdaq — here’s what’s moving ABVX and what’s next

New York, Jan 7, 2026, 11:10 EST — Regular session Shares of Abivax SA jumped 7.3% to $127.75 in morning trading on Wednesday, after touching a session high of $128.87 and a low of $119.48. Trading volume topped 700,000 shares. The French biotech’s U.S.-listed stock has become a fast-moving name for healthcare traders, in part because its valuation rests on…

Stock Market Today

  • Experts Advise Diversified Investment Strategies for 2026 Amid Mixed Market Signals
    January 25, 2026, 1:14 PM EST. Investment experts advise caution as markets enter 2026 with a mixed outlook. While international stocks showed strong returns last year, aided by attractive valuations and a weak U.S. dollar, their edge may persist but is not guaranteed. The U.S. market's performance hinges largely on the pace of the artificial intelligence (AI) sector rebound, with key tech giants lagging. Valuations in the U.S. remain higher than overseas, suggesting that investors should pursue a diversified portfolio. In Canada, natural resources like gold and oil, alongside financial stocks, remain prominent but carry valuation risks. Opportunities may be limited by unclear drivers for oil prices and stretched precious metals. Overall, experts urge investors to assess sector fundamentals and global conditions carefully.
Go toTop